Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Randomized Phase IV Study of the Safety and Efficacy of ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis

NCT01926054 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT01926054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01926054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Randomized Phase IV Study of the Safety and Efficacy of ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis
Lead sponsor
Ohio State University
Phase
Phase 4
Overall status
Withdrawn
Start date
July 31, 2013
Completion date
February 28, 2018
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sle glomerulonephritis syndrome, who class v